Exicure, Inc. aksje
XCUR
$2.3100+0.2100 (+10.00%)
Laster graf...
Exicure, Inc.
Åpning2.3450
Høy2.4800
Lav2.1100
Volum53.02k
P/EN/A
Markedsverdi14.72M
52-ukers høy9.5000
52-ukers lav1.7100
Gj.sn. volum19.07k
UtbytteN/A
Beta3.54
EPS-1.5000
Om Exicure, Inc. aksje
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Selskapsinformasjon
Børs: NasdaqCM (NCM)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
400 Seaport Court
94063 Redwood City, United States
94063 Redwood City, United States
Telefon: + 847 673 1700
Nettside: https://www.exicuretx.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål